Cross-trial Analysis of Immunologic and Clinical Data Resulting From Phase I and II Trials of MVA-5T4 (TroVax) in Colorectal, Renal, and Prostate Cancer Patients

Richard Harrop; William Shingler; Michelle Kelleher; Jackie de Belin; Peter Treasure

doi:10.1097/cji.0b013e3181f5dac7

Cross-trial Analysis of Immunologic and Clinical Data Resulting From Phase I and II Trials of MVA-5T4 (TroVax) in Colorectal, Renal, and Prostate Cancer Patients

Journal of Immunotherapy ◽

10.1097/cji.0b013e3181f5dac7 ◽

2010 ◽

Vol 33 (9) ◽

pp. 999-1005 ◽

Cited By ~ 27

Author(s):

Richard Harrop ◽

William Shingler ◽

Michelle Kelleher ◽

Jackie de Belin ◽

Peter Treasure

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Cancer Patients ◽

Clinical Data ◽

Trial Analysis ◽

Phase I And Ii

Download Full-text

601 POSTER Cross-trial analysis of immunological and clinical data resulting from phase I and II trials of MVA-5T4 (TroVax®) in colorectal, renal and prostate cancer patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(08)72535-7 ◽

2008 ◽

Vol 6 (12) ◽

pp. 188

Author(s):

R. Harrop ◽

W.H. Shingler ◽

N. Drury ◽

M. Goonewardena ◽

J. de Belin ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Cancer Patients ◽

Clinical Data ◽

Trial Analysis ◽

Phase I And Ii

Download Full-text

Zoledronic acid in cancer patients with bone metastases: Results of Phase I and II trials

Seminars in Oncology ◽

10.1053/sonc.2001.24157 ◽

2001 ◽

Vol 28 (2C) ◽

pp. 25-34 ◽

Cited By ~ 1

Author(s):

James R. Berenson

Keyword(s):

Zoledronic Acid ◽

Phase I ◽

Bone Metastases ◽

Cancer Patients ◽

Phase I And Ii

Download Full-text

A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients

Acta Oncologica ◽

10.1080/0284186x.2021.1979246 ◽

2021 ◽

pp. 1-6

Author(s):

Stine E. Petersen ◽

Lise B. Thorsen ◽

Steinbjørn Hansen ◽

Peter M. Petersen ◽

Henriette Lindberg ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase I ◽

Cancer Patients ◽

Pelvic Radiation ◽

High Risk Prostate Cancer ◽

Patient Reported ◽

Risk Prostate Cancer

Download Full-text

Phase I and II trials in pediatric cancer patients: a rationale

The Role of Pharmacology in Pediatric Oncology ◽

10.1007/978-94-009-4267-7_10 ◽

1987 ◽

pp. 159-170 ◽

Cited By ~ 2

Author(s):

Richard S. Ungerleider ◽

Silvia Marsoni

Keyword(s):

Phase I ◽

Cancer Patients ◽

Pediatric Cancer ◽

Pediatric Cancer Patients ◽

Phase I And Ii

Download Full-text

The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study

The Prostate ◽

10.1002/pros.21362 ◽

2011 ◽

Vol 71 (13) ◽

pp. 1455-1465 ◽

Cited By ~ 68

Author(s):

Jayaprakash Karkera ◽

Hannes Steiner ◽

Weimin Li ◽

Viktor Skradski ◽

Patrizia L. Moser ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Cancer Patients ◽

Interleukin 6 ◽

Phase I Study

Download Full-text

Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical data

Experimental and Therapeutic Medicine ◽

10.3892/etm_00000099 ◽

2010 ◽

Vol 1 (4) ◽

pp. 635-639 ◽

Cited By ~ 3

Author(s):

YOSHIAKI YAMADA ◽

KATSUYA NARUSE ◽

KOGENTA NAKAMURA ◽

TOMOHIRO TAKI ◽

MOTOI TOBIUME ◽

...

Keyword(s):

Prostate Cancer ◽

Risk Factors ◽

Bone Metastasis ◽

Cancer Patients ◽

Clinical Data

Download Full-text

Results from a first in man Phase I/II adjuvant Dendritic Cell Vaccine study in high risk prostate cancer patients following radical surgery

Cytotherapy ◽

10.1016/j.jcyt.2017.02.025 ◽

2017 ◽

Vol 19 (5) ◽

pp. S15 ◽

Cited By ~ 1

Author(s):

A.A. Tryggestad ◽

I. Bigalke ◽

K. Axcrona ◽

E. Inderberg ◽

G. Skorstad ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Phase I ◽

Cancer Patients ◽

Radical Surgery ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

A26. A phase I/II pilot trial of low-dose, sustained-release GTN for prostate cancer patients with recurrence after primary therapy

Nitric Oxide ◽

10.1016/j.niox.2007.09.031 ◽

2007 ◽

Vol 17 ◽

pp. 15 ◽

Cited By ~ 8

Author(s):

D.R. Siemens ◽

J. Heaton ◽

M. Adams ◽

C. Graham

Keyword(s):

Prostate Cancer ◽

Sustained Release ◽

Phase I ◽

Cancer Patients ◽

Low Dose ◽

Pilot Trial ◽

Primary Therapy

Download Full-text

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results from a phase I clinical trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.2507 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 2507-2507

Author(s):

Z. Su ◽

J. W. Vieweg ◽

J. Dannull ◽

P. Dahm

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Dendritic Cells ◽

Fusion Protein ◽

Phase I ◽

Cancer Patients ◽

Mhc Class Ii ◽

Metastatic Prostate Cancer ◽

Class Ii ◽

Phase I Clinical Trial

Download Full-text

Radium-223 chloride, a first-in-class alpha-pharmaceutical with a benign safety profile for patients with castration-resistant prostate cancer (CRPC) and bone metastases: Combined analysis of phase I and II clinical trials.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.4678 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 4678-4678 ◽

Cited By ~ 3

Author(s):

S. Nilsson ◽

C. Parker ◽

I. Haugen ◽

A. Lokna ◽

A. Aksnes ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Phase I ◽

Bone Metastases ◽

Safety Profile ◽

Castration Resistant Prostate Cancer ◽

Combined Analysis ◽

Castration Resistant ◽

Radium 223 ◽

Phase I And Ii

Download Full-text